Active Ingredient: CABOTEGRAVIR
Proprietary Name: APRETUDE
Dosage Form; Route of Administration: SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR
Strength: 600MG/3ML (200MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N215499
Product Number: 001
Approval Date: Dec 20, 2021
Applicant Holder Full Name: VIIV HEALTHCARE CO
Marketing Status:
Prescription
Patent and Exclusivity Information
